LSI vs MREO
LSI (LSI) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
LSI does not have a complete income-statement cache yet.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
MREO currently screens at market cap $48.7M.
Not investment advice. Open the LSI and MREO stock pages for the full models.
Not investment advice.